Repligen (RGEN) Reports In-Line Q3 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Repligen (RGEN) Reports In-Line Q3 EPS

Repligen Reports Third Quarter 2015 Financial Results

November 5, 2015 7:31 AM EST

- Product Sales Increase 31% to $19.8 Million -

- Conference Call and Webcast Today at 8:30 a.m. ET -

WALTHAM, Mass., Nov. 05, 2015 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for the third quarter and nine-month (year-to-date) periods ended September 30, 2015. Below are the Companys performance highlights, followed by updated financial guidance for the year 2015 and access information for todays webcast and conference call.

Third Quarter and Year-to-Date Financial... More